SPRC (SciSparc) Shiller PE Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SPRC SciSparc Ltd SPRC
41 GF Score
Price $5.20
GF Value $3.01
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SciSparc Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


SciSparc  (NAS:SPRC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


SciSparc Shiller PE Ratio Related Terms


SciSparc Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for SciSparc's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciSparc Shiller PE Ratio Chart

SciSparc Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SciSparc Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SPRC vs VIVS, GOVX, SXTP: Shiller PE Ratio Comparison

For the Biotechnology subindustry, SciSparc's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciSparc Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SciSparc's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SciSparc's Shiller PE Ratio falls into.


SPRC
41GF Score
SciSparc Ltd SPRC
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SciSparc Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

SciSparc's E10 for the fiscal year that ended in Dec25 is calculated as:

For example, SciSparc's adjusted earnings per share data for the fiscal year that ended in Dec25 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec25 (Change)*Current CPI (Dec25)
=98.07/324.0540*324.0540
=98.070

Current CPI (Dec25) = 324.0540.

SciSparc Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201612 -245.700 241.432 -329.783
201712 -245.700 246.524 -322.971
201812 -5,896.800 251.233 -7,606.014
201912 -58.670 256.974 -73.985
202012 -3.358 260.474 -4.178
202112 -9,203.498 278.802 -10,697.306
202212 -1,874.187 296.797 -2,046.307
202312 2,374.550 306.746 2,508.533
202412 203.890 315.605 209.348
202512 98.070 324.054 98.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is SciSparc (SPRC) Overvalued in 2026?

Based on GuruFocus' analysis, SciSparc stock appears to be overvalued. The current stock price of $5.20 is trading 72.8% above its estimated GF Value™ of $3.01. GuruFocus considers SciSparc to be Significantly Overvalued.

Key valuation signals for SPRC:

  • Shiller PE Ratio:
  • GF Value™: $3.01 vs. price of $5.20 (72.8% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the SPRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SciSparc Business Description

Address 20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
41GF Score

Get the complete analysis for SPRC

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.20
Price
$3.01
GF Value